Inhibitory receptors on myeloid cells: New targets for therapy?

Pharmacology and Therapeutics

Volumn 125, Issue 1, 2010, Pages 128-137

  Munitz, Ariel ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Immunoreceptor tyrosine based inhibitory motif (ITIM); Inflammation; Inhibitory receptor; Myeloid cells

Indexed keywords

ANTIALLERGIC AGENT; CD200 ANTIGEN; CELL RECEPTOR; CHEMOKINE RECEPTOR; CYTOKINE; DEXAMETHASONE; FC RECEPTOR IIB; GLUCOCORTICOID; GROWTH FACTOR; IMMUNOGLOBULIN RECEPTOR; LECTIN; LIGAND;

ALLERGY; BONE MARROW CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; HEMATOPOIESIS; HOMEOSTASIS; HUMAN; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; LOW DRUG DOSE; NATURAL KILLER CELL; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SIGNAL TRANSDUCTION; SKIN ANAPHYLAXIS;

ANIMALS; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; HYPERSENSITIVITY; IMMUNITY, INNATE; INFLAMMATION; LIGANDS; MYELOID CELLS; PROTEIN CONFORMATION; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 72049132624     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2009.10.007     Document Type: Review

References (100)

1. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
2. Alblas J., Honing H., de Lavalette C.R., Brown M.H., Dijkstra C.D., and van den Berg T.K. Signal regulatory protein alpha ligation induces macrophage nitric oxide production through JAK/STAT- and phosphatidylinositol 3-kinase/Rac1/NAPDH oxidase/H2O2-dependent pathways. Mol Cell Biol 25 (2005) 7181-7192
3. Alvarez Y., Tang X., Coligan J.E., and Borrego F. The CD300a (IRp60) inhibitory receptor is rapidly up-regulated on human neutrophils in response to inflammatory stimuli and modulates CD32a (FcgammaRIIa) mediated signaling. Mol Immunol 45 (2008) 253-258
4. Ando M., Tu W., Nishijima K., and Iijima S. Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs. Biochem Biophys Res Commun 369 (2008) 878-883
5. Bachelet I., Munitz A., and Levi-Schaffer F. Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a. J Allergy Clin Immunol 117 (2006) 1314-1320
6. Bachelet I., Munitz A., Moretta A., Moretta L., and Levi-Schaffer F. The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells. J Immunol 175 (2005) 7989-7995
7. Barclay A.N., Wright G.J., Brooke G., and Brown M.H. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol 23 (2002) 285-290
8. Barrow A.D., and Trowsdale J. You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling. Eur J Immunol 36 (2006) 1646-1653
9. Berg K.L., Siminovitch K.A., and Stanley E.R. SHP-1 regulation of p62(DOK) tyrosine phosphorylation in macrophages. J Biol Chem 274 (1999) 35855-35865
10. Brooks A.G., Posch P.E., Scorzelli C.J., Borrego F., and Coligan J.E. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J Exp Med 185 (1997) 795-800
11. Brown E.J. Leukocyte migration: dismantling inhibition. Trends Cell Biol 15 (2005) 393-395
12. Campbell K.S., and Colonna M. Human natural killer cell receptors and signal transduction. Int Rev Immunol 20 (2001) 333-370
13. Can I., Tahara-Hanaoka S., Hitomi K., Nakano T., Nakahashi-Oda C., Kurita N., et al. Caspase-independent cell death by CD300LF (MAIR-V), an inhibitory immunoglobulin-like receptor on myeloid cells. J Immunol 180 (2008) 207-213
14. Cantoni C., Bottino C., Augugliaro R., Morelli L., Marcenaro E., Castriconi R., et al. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol 29 (1999) 3148-3159
15. Castells M.C., Klickstein L.B., Hassani K., Cumplido J.A., Lacouture M.E., Austen K.F., et al. gp49B1-alpha(v)beta3 interaction inhibits antigen-induced mast cell activation. Nat Immunol 2 (2001) 436-442
16. Cella M., Dohring C., Samaridis J., Dessing M., Brockhaus M., Lanzavecchia A., et al. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 185 (1997) 1743-1751
17. Chen C.H., Floyd H., Olson N.E., Magaletti D., Li C., Draves K., et al. Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production. Blood 107 (2006) 1459-1467
18. Chen G.Y., Tang J., Zheng P., and Liu Y. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323 (2009) 1722-1725
19. Chung D.H., Humphrey M.B., Nakamura M.C., Ginzinger D.G., Seaman W.E., and Daws M.R. CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. J Immunol 171 (2003) 6541-6548
20. Clark G.J., Ju X., Tate C., and Hart D.N. The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. Trends Immunol 30 (2009) 209-217
21. Colonna M. Natural killer cell receptors specific for MHC class I molecules. Curr Opin Immunol 8 (1996) 101-107
22. Cooper M.D. Inhibition of immune cell function. Immunol Rev 224 (2008) 7-10
23. Cotton M., and Claing A. G protein-coupled receptors stimulation and the control of cell migration. Cell Signal 21 (2009) 1045-1053
24. Crocker P.R., Paulson J.C., and Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol 7 (2007) 255-266
25. Daeron M. Intracytoplasmic sequences involved in the biological properties of low-affinity receptors for IgG expressed by murine macrophages. Braz J Med Biol Res 28 (1995) 263-274
26. Daeron M., Jaeger S., Du Pasquier L., and Vivier E. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future. Immunol Rev 224 (2008) 11-43
27. den Dunnen J., Gringhuis S.I., and Geijtenbeek T.B. Innate signaling by the C-type lectin DC-SIGN dictates immune responses. Cancer Immunol Immunother 58 (2009) 1149-1157
28. Dexter T.M., and Spooncer E. Growth and differentiation in the hemopoietic system. Annu Rev Cell Biol 3 (1987) 423-441
29. Dietrich J., Nakajima H., and Colonna M. Human inhibitory and activating Ig-like receptors which modulate the function of myeloid cells. Microbes Infect 2 (2000) 323-329
30. Fong D.C., Malbec O., Arock M., Cambier J.C., Fridman W.H., and Daeron M. Selective in vivo recruitment of the phosphatidylinositol phosphatase SHIP by phosphorylated Fc gammaRIIB during negative regulation of IgE-dependent mouse mast cell activation. Immunol Lett 54 (1996) 83-91
31. Fournier N., Chalus L., Durand I., Garcia E., Pin J.J., Churakova T., et al. FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells. J Immunol 165 (2000) 1197-1209
32. Gagliardi M.C., Teloni R., Giannoni F., Pardini M., Sargentini V., Brunori L., et al. Mycobacterium bovis Bacillus Calmette-Guerin infects DC-SIGN - dendritic cell and causes the inhibition of IL-12 and the enhancement of IL-10 production. J Leukoc Biol 78 (2005) 106-113
33. Geijtenbeek T.B., and Gringhuis S.I. Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol 9 (2009) 465-479
34. Gerber J.S., and Mosser D.M. Stimulatory and inhibitory signals originating from the macrophage Fcgamma receptors. Microbes Infect 3 (2001) 131-139
35. Gordon S., and Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 5 (2005) 953-964
36. Grazia Cappiello M., Sutterwala F.S., Trinchieri G., Mosser D.M., and Ma X. Suppression of Il-12 transcription in macrophages following Fc gamma receptor ligation. J Immunol 166 (2001) 4498-4506
37. Held W., Cado D., and Raulet D.H. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. J Exp Med 184 (1996) 2037-2041
38. Hiragun T., Peng Z., and Beaven M.A. Dexamethasone up-regulates the inhibitory adaptor protein Dok-1 and suppresses downstream activation of the mitogen-activated protein kinase pathway in antigen-stimulated RBL-2H3 mast cells. Mol Pharmacol 67 (2005) 598-603
39. Kanazawa N., Tashiro K., and Miyachi Y. Signaling and immune regulatory role of the dendritic cell immunoreceptor (DCIR) family lectins: DCIR, DCAR, dectin-2 and BDCA-2. Immunobiology 209 (2004) 179-190
40. Kane M.M., and Mosser D.M. The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 166 (2001) 1141-1147
41. Katz H.R. Inhibition of pathologic inflammation by leukocyte Ig-like receptor B4 and related inhibitory receptors. Immunol Rev 217 (2007) 222-230
42. Kong X.N., Yan H.X., Chen L., Dong L.W., Yang W., Liu Q., et al. LPS-induced down-regulation of signal regulatory protein alpha contributes to innate immune activation in macrophages. J Exp Med 204 (2007) 2719-2731
43. Lanier L.L. NK cell receptors. Annu Rev Immunol 16 (1998) 359-393
44. Lebbink R.J., and Meyaard L. Non-MHC ligands for inhibitory immune receptors: novel insights and implications for immune regulation. Mol Immunol 44 (2007) 2153-2164
45. Lebbink R.J., de Ruiter T., Adelmeijer J., Brenkman A.B., van Helvoort J.M., Koch M., et al. Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med 203 (2006) 1419-1425
46. Long E.O. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 17 (1999) 875-904
47. Long E.O. Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol Rev 224 (2008) 70-84
48. Lu W., Gong D., Bar-Sagi D., and Cole P.A. Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. Mol Cell 8 (2001) 759-769
49. Lu-Kuo J.M., Joyal D.M., Austen K.F., and Katz H.R. gp49B1 inhibits IgE-initiated mast cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of src homology 2 domain-containing phosphatase-1, and suppression of early and late calcium mobilization. J Biol Chem 274 (1999) 5791-5796
50. Masuda A., Nakamura A., Maeda T., Sakamoto Y., and Takai T. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. J Exp Med 204 (2007) 907-920
51. Meyaard L., Adema G.J., Chang C., Woollatt E., Sutherland G.R., Lanier L.L., et al. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 7 (1997) 283-290
52. Miles S.A., Conrad S.M., Alves R.G., Jeronimo S.M., and Mosser D.M. A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J Exp Med 201 (2005) 747-754
53. Mingari M.C., Vitale C., Romagnani C., Falco M., and Moretta L. p75/AIRM1 and CD33, two sialoadhesin receptors that regulate the proliferation or the survival of normal and leukemic myeloid cells. Immunol Rev 181 (2001) 260-268
54. Moretta A., Bottino C., Mingari M.C., Biassoni R., and Moretta L. What is a natural killer cell?. Nat Immunol 3 (2002) 6-8
55. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M.C., et al. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 14 (1996) 619-648
56. Mori Y., Tsuji S., Inui M., Sakamoto Y., Endo S., Ito Y., et al. Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development. J Immunol 181 (2008) 4742-4751
57. Munitz A., and Levi-Schaffer F. Eosinophils: 'new' roles for 'old' cells. Allergy 59 (2004) 268-275
58. Munitz A., and Levi-Schaffer F. Inhibitory receptors on eosinophils: a direct hit to a possible Achilles heel?. J Allergy Clin Immunol 119 (2007) 1382-1387
59. Munitz A., Bachelet I., Eliashar R., Moretta A., Moretta L., and Levi-Schaffer F. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 107 (2006) 1996-2003
60. Munitz A., Bachelet I., and Levi-Schaffer F. Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. J Allergy Clin Immunol 118 (2006) 1082-1089
61. Munitz A., McBride M.L., Bernstein J.S., and Rothenberg M.E. A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils. Blood 111 (2008) 5694-5703
62. Munitz A., Piliponsky A.M., and Levi-Schaffer F. IgE-independent activation of human mast cells indicates their role in the late phase reaction of allergic inflammation. Cell Tissue Bank 4 (2003) 25-28
63. Nakayama M., Underhill D.M., Petersen T.W., Li B., Kitamura T., Takai T., et al. Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. J Immunol 178 (2007) 4250-4259
64. Nutku E., Aizawa H., Hudson S.A., and Bochner B.S. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood 101 (2003) 5014-5020
65. Nutku E., Hudson S.A., and Bochner B.S. Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury. Biochem Biophys Res Commun 336 (2005) 918-924
66. Nutku-Bilir E., Hudson S.A., and Bochner B.S. Interleukin-5 priming of human eosinophils alters siglec-8 mediated apoptosis pathways. Am J Respir Cell Mol Biol 38 (2008) 121-124
67. Ochi S., Shinohara M., Sato K., Gober H.J., Koga T., Kodama T., et al. Pathological role of osteoclast costimulation in arthritis-induced bone loss. Proc Natl Acad Sci U S A 104 (2007) 11394-11399
68. Pereira S., Zhang H., Takai T., and Lowell C.A. The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling. J Immunol 173 (2004) 5757-5765
69. Pinheiro da Silva F., Aloulou M., Benhamou M., and Monteiro R.C. Inhibitory ITAMs: a matter of life and death. Trends Immunol 29 (2008) 366-373
70. Ravetch J.V., and Lanier L.L. Immune inhibitory receptors. Science 290 (2000) 84-89
71. Relloso M., Puig-Kroger A., Pello O.M., Rodriguez-Fernandez J.L., de la Rosa G., Longo N., et al. DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents. J Immunol 168 (2002) 2634-2643
72. Richard M., Thibault N., Veilleux P., Breton R., and Beaulieu A.D. The ITIM-bearing CLECSF6 (DCIR) is down-modulated in neutrophils by neutrophil activating agents. Biochem Biophys Res Commun 310 (2003) 767-773
73. Robinson M.J., Sancho D., Slack E.C., LeibundGut-Landmann S., and Reis C. e Sousa: Myeloid C-type lectins in innate immunity. Nat Immunol 7 (2006) 1258-1265
74. Robson J.D., Davidson D., and Veillette A. Inhibition of the Jun N-terminal protein kinase pathway by SHIP-1, a lipid phosphatase that interacts with the adaptor molecule Dok-3. Mol Cell Biol 24 (2004) 2332-2343
75. Rothenberg M.E. Eosinophilia. N Engl J Med 338 (1998) 1592-1600
76. Rozengurt E. Mitogenic signaling pathways induced by G protein-coupled receptors. J Cell Physiol 213 (2007) 589-602
77. Saxon A., Kepley C., and Zhang K. "Accentuate the negative, eliminate the positive": engineering allergy therapeutics to block allergic reactivity through negative signaling. J Allergy Clin Immunol 121 (2008) 320-325
78. Saxon A., Zhu D., Zhang K., Allen L.C., and Kepley C.L. Genetically engineered negative signaling molecules in the immunomodulation of allergic diseases. Curr Opin Allergy Clin Immunol 4 (2004) 563-568
79. Sayos J., Martinez-Barriocanal A., Kitzig F., Bellon T., and Lopez-Botet M. Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j. Biochem Biophys Res Commun 324 (2004) 640-647
80. Shiratori I., Ogasawara K., Saito T., Lanier L.L., and Arase H. Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor. J Exp Med 199 (2004) 525-533
81. Sinclair N.R. Why so many coinhibitory receptors?. Scand J Immunol 50 (1999) 10-13
82. Staub E., Rosenthal A., and Hinzmann B. Systematic identification of immunoreceptor tyrosine-based inhibitory motifs in the human proteome. Cell Signal 16 (2004) 435-456
83. Takai T. Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology 115 (2005) 433-440
84. Tam S.W., Demissie S., Thomas D., and Daeron M. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils. Allergy 59 (2004) 772-780
85. Taylor P.R., and Gordon S. Monocyte heterogeneity and innate immunity. Immunity 19 (2003) 2-4
86. Torii I., Oka S., Hotomi M., Benjamin Jr. W.H., Takai T., Kearney J.F., et al. PIR-B-deficient mice are susceptible to Salmonella infection. J Immunol 181 (2008) 4229-4239
87. Vatinel S., Ferrand A., Lopez F., Kowalski-Chauvel A., Esteve J.P., Fourmy D., et al. An ITIM-like motif within the CCK2 receptor sequence required for interaction with SHP-2 and the activation of the AKT pathway. Biochim Biophys Acta 1763 (2006) 1098-1107
88. Verbrugge A., Rijkers E.S., de Ruiter T., and Meyaard L. Leukocyte-associated Ig-like receptor-1 has SH2 domain-containing phosphatase-independent function and recruits C-terminal Src kinase. Eur J Immunol 36 (2006) 190-198
89. Vitale C., Romagnani C., Falco M., Ponte M., Vitale M., Moretta A., et al. Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells. Proc Natl Acad Sci U S A 96 (1999) 15091-15096
90. Vitale C., Romagnani C., Puccetti A., Olive D., Costello R., Chiossone L., et al. Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: engagement of CD33 induces apoptosis of leukemic cells. Proc Natl Acad Sci U S A 98 (2001) 5764-5769
91. von Gunten S., Yousefi S., Seitz M., Jakob S.M., Schaffner T., Seger R., et al. Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment. Blood 106 (2005) 1423-1431
92. Wagner C.S., Walther-Jallow L., Buentke E., Ljunggren H.G., Achour A., and Chambers B.J. Human cytomegalovirus-derived protein UL18 alters the phenotype and function of monocyte-derived dendritic cells. J Leukoc Biol 83 (2008) 56-63
93. Wu J., Cherwinski H., Spies T., Phillips J.H., and Lanier L.L. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J Exp Med 192 (2000) 1059-1068
94. Zhang S., and Phillips J.H. Identification of tyrosine residues crucial for CD200R-mediated inhibition of mast cell activation. J Leukoc Biol 79 (2006) 363-368
95. Zhang H., Meng F., Chu C.L., Takai T., and Lowell C.A. The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B. Immunity 22 (2005) 235-246
96. Zhang Z., Shen K., Lu W., and Cole P.A. The role of C-terminal tyrosine phosphorylation in the regulation of SHP-1 explored via expressed protein ligation. J Biol Chem 278 (2003) 4668-4674
97. Zhou J.S., Friend D.S., Feldweg A.M., Daheshia M., Li L., Austen K.F., et al. Prevention of lipopolysaccharide-induced microangiopathy by gp49B1: evidence for an important role for gp49B1 expression on neutrophils. J Exp Med 198 (2003) 1243-1251
98. Zhu D., Kepley C.L., Zhang K., Terada T., Yamada T., and Saxon A. A chimeric human-cat fusion protein blocks cat-induced allergy. Nat Med 11 (2005) 446-449
99. Zhu D., Kepley C.L., Zhang M., Zhang K., and Saxon A. A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation. Nat Med 8 (2002) 518-521
100. Zocchi M.R., Pellegatta F., Pierri I., Gobbi M., and Poggi A. Leukocyte-associated Ig-like receptor-1 prevents granulocyte-monocyte colony stimulating factor-dependent proliferation and Akt1/PKB alpha activation in primary acute myeloid leukemia cells. Eur J Immunol 31 (2001) 3667-3675